Results 291 to 294 of about 518,432 (294)

Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers. [PDF]

Front Oncol
Kluitmans DJF, Melis JJTM, van den Bossche E, Ytsma J, de Roos JADM, van Linden OPJ, Grobben Y, Kooijman JJ, Zaman GJR.   +8 more
europepmc   +1 more source

Chemical proteomics decrypts the kinases that shape the dynamic human phosphoproteome

Bayer FP, Müller J, Kabella N, Abele M, Chang Y, Estrada Duenas LD, Jensen C, Hamood F, Lee C, Schneider A, The M, Kuster B.   +11 more
europepmc   +1 more source